Litcius/Paper detail

Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer’s disease

Golaleh Ghotbi, Mohammad Mahdavi, Zahra Najafi, Farshad Homayouni Moghadam, Maryam Hamzeh‐Mivehroud, Soodabeh Davaran, Siavoush Dastmalchi

2020Bioorganic Chemistry59 citationsDOI

Topics & Concepts

ChemistryAcetylcholinesteraseButyrylcholinesteraseAchéDonepezilNeuroprotectionThiazoleIC50Docking (animal)Inhibitory postsynaptic potentialBiochemistryEnzymeIn vitroPharmacologyStereochemistryBiologyPathologyNursingNeuroscienceDementiaMedicineDiseaseCholinesterase and Neurodegenerative DiseasesComputational Drug Discovery MethodsAlzheimer's disease research and treatments
Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer’s disease | Litcius